Gilder Gagnon Howe & Co’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,982,257
Closed -$23.4M 263
2022
Q2
$23.4M Sell
2,982,257
-1,759,009
-37% -$15.1M 0.42% 67
2022
Q1
$52.5M Sell
4,741,266
-373,862
-7% -$4.19M 0.49% 60
2021
Q4
$89.9M Sell
5,115,128
-172,975
-3% -$3.36M 0.51% 65
2021
Q3
$107M Sell
5,288,103
-547,639
-9% -$14.1M 0.56% 58
2021
Q2
$193M Sell
5,835,742
-19,628
-0.3% -$741K 0.95% 26
2021
Q1
$229M Sell
5,855,370
-226,328
-4% -$10.6M 1.23% 19
2020
Q4
$265M Buy
6,081,698
+1,925,389
+46% +$65.8M 1.32% 18
2020
Q3
$118M Buy
4,156,309
+1,729,761
+71% +$54.6M 0.73% 40
2020
Q2
$88.1M Buy
2,426,548
+839,896
+53% +$23.7M 0.69% 47
2020
Q1
$28.8M Buy
+1,586,652
New +$34.8M 0.35% 82

Other funds holding ONEM

Gilder Gagnon Howe & Co's ONEM Position: Q3 2022 in Review

Gilder Gagnon Howe & Co sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 2,982,257 shares — an estimated $23.4M sold.

Gilder Gagnon Howe & Co first reported a position in ONEM in Q1 2020 and held it in 10 quarters. The position peaked at $265M in Q4 2020. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Gilder Gagnon Howe & Co reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 2,982,257 1Life Healthcare shares in Q3 2022, an estimated $23.4M.
  • Gilder Gagnon Howe & Co first reported a position in 1Life Healthcare in Q1 2020 and held it in 10 quarters.
  • Gilder Gagnon Howe & Co's 1Life Healthcare position peaked at $265M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.